Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 26;26(7):1895.
doi: 10.3390/molecules26071895.

Anti-Inflammatory Effect of Phytoncide in an Animal Model of Gastrointestinal Inflammation

Affiliations

Anti-Inflammatory Effect of Phytoncide in an Animal Model of Gastrointestinal Inflammation

Azra Memon et al. Molecules. .

Abstract

Background: Phytoncide is known to have antimicrobial and anti-inflammatory properties. Purpose: This study was carried out to confirm the anti-inflammatory activity of two types of phytoncide extracts from pinecone waste. Methods: We made two types of animal models to evaluate the efficacy, an indomethacin-induced gastroenteritis rat model and a dextran sulfate sodium-induced colitis mouse model. Result: In the gastroenteritis experiment, the expression of induced-nitric oxide synthase (iNOS), a marker for inflammation, decreased in the phytoncide-supplemented groups, and gastric ulcer development was significantly inhibited (p < 0.05). In the colitis experiment, the shortening of the colon length and the iNOS expression were significantly suppressed in the phytoncide-supplemented group (p < 0.05). Conclusions: Through this study, we confirmed that phytoncide can directly inhibit inflammation in digestive organs. Although further research is needed, we conclude that phytoncide has potential anti-inflammatory properties in the digestive tract and can be developed as a functional agent.

Keywords: Pinus koraiensis; anti-inflammation; colitis; gastritis; phytoncide.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Effect of phytoncide on an indomethacin-induced gastric ulcer. (A) Photograph of the stomach of a rat with indomethacin-induced gastritis, (B) gastric ulcer scoring graph of a rat with indomethacin-induced gastritis. G1, normal control; G2, Vehicle control (gastric ulcer control, indomethacin 80 mg/kg); G3, positive control (lansoprazole 30 mg/kg); G4, phytoncide oil 10 mL/kg; G5, phytoncide oil 5 mL/kg; G6, pine cone water extract 10 mL/kg; G7, pine cone water extract 5 mL/kg. Representative data are expressed as mean ± SEM of experiments (n = 10) for each group. *** p < 0.001 compared to vehicle control.
Figure 2
Figure 2
Effect of phytoncide treatment on histological changes in indomethacin-induced gastric damage. (A) Results of the H&E staining, × 100 magnification. (B) Effect of phytoncide on histological scores of the indomethacin-induced gastric ulcer. G1, normal control; G2, vehicle control (gastric ulcer control, indomethacin 80 mg/kg); G3, positive control (lansoprazole 30 mg/kg); G4, phytoncide oil 10 mL/kg; G5, phytoncide oil 5 mL/kg; G6, pine cone water extract 10 mL/kg; G7, pine cone water extract 5 mL/kg. Representative data are expressed as mean ± SEM of experiments (n = 10) for each group. ** p < 0.01 and *** p < 0.001 compared to vehicle control.
Figure 3
Figure 3
Immunohistochemical analysis: effect of phytoncide treatment on iNOS expression in indomethacin-induced gastric damage. (A) Photograph of stomach tissue from rat with indomethacin-induced gastritis, × 100 magnification. (B) iNOS expression graph of rat with indomethacin-induced gastritis. G1, normal control; G2, vehicle control (gastric ulcer control, indomethacin 80 mg/kg); G3, positive control (lansoprazole 30 mg/kg); G4, phytoncide oil 10 mL/kg; G5, phytoncide oil 5 mL/kg; G6, pine cone water extract 10 mL/kg; G7, pine cone water extract 5 mL/kg. *** p < 0.001 compared to vehicle control.
Figure 4
Figure 4
Effect of phytoncide treatment on symptoms of mice with DSS-induced colitis. (A) Effect of phytoncide treatment on body weight change in mice with DSS-induced colitis, (B) effect of phytoncide treatment in photograph of colon tissues of mice with DSS-induced colitis, (C) graphs of colon length, (D) effect of phytoncide treatment on disease activity index in mice with DSS-induced colitis. G1, normal control; G2, vehicle control (colitis control, DSS 2% in DW); G3, prevention phytoncide oil 10 mL/kg; G4, therapy phytoncide oil 10 mL/kg; G5, prevention pine cone water extract 10 mL/kg; G6, therapy pine cone water extract 10 mL/kg. Representative data are expressed as mean ± SEM of experiments (n = 10) for each group. #p < 0.05 compare to normal control. * p < 0.05 and ** p < 0.01 compared to vehicle control.
Figure 5
Figure 5
Effect of phytoncide treatment on histological changes on DSS-induced colitis damage. (A) Results of the H&E staining, × 100 magnification. (B) Effect of phytoncide on histological scores of DSS-induced colitis. G1, normal control; G2, vehicle control (colitis control, DSS 2% in DW); G3, prevention phytoncide oil 10 mL/kg; G4, therapy phytoncide oil 10 mL/kg; G5, prevention pine cone water extract 10 mL/kg; G6, therapy pine cone water extract 10 mL/kg. Representative data are expressed as mean ± SEM of experiments (n = 10) for each group. ** p < 0.01 compared to vehicle control.
Figure 5
Figure 5
Effect of phytoncide treatment on histological changes on DSS-induced colitis damage. (A) Results of the H&E staining, × 100 magnification. (B) Effect of phytoncide on histological scores of DSS-induced colitis. G1, normal control; G2, vehicle control (colitis control, DSS 2% in DW); G3, prevention phytoncide oil 10 mL/kg; G4, therapy phytoncide oil 10 mL/kg; G5, prevention pine cone water extract 10 mL/kg; G6, therapy pine cone water extract 10 mL/kg. Representative data are expressed as mean ± SEM of experiments (n = 10) for each group. ** p < 0.01 compared to vehicle control.
Figure 6
Figure 6
Result of immunohistochemical analysis: effect of phytoncide treatment on iNOS expression in DSS-induced colitis damage. (A) Photograph of colon from mouse with DSS-induced colitis, × 100 magnification. (B) iNOS expression graph of mouse with DSS-induced colitis. G1, normal control; G2, vehicle control (colitis control, DSS 2% in DW); G3, prevention phytoncide oil 10 mL/kg; G4, therapy phytoncide oil 10 mL/kg; G5, prevention pine cone water extract 10 mL/kg; G6, therapy pine cone water extract 10 mL/kg. ** p < 0.01 compared to vehicle control.

Similar articles

Cited by

References

    1. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high-risk patient. Gastroenerology. 2001;120:597–606. doi: 10.1053/gast.2001.21907. - DOI - PubMed
    1. Whitfield-Cargile C.M., Cohen N.D., Chapkin R.S., Weeks B.R., Davidson L.A., Goldsby J.S., Hunt C.L., Steinmeyer S.H., Menon R., Suchodolski J.S., et al. The microbiota-derived metabolite indole decreases mucosal inflammation and injury in a murine model of NSAID enteropathy. Gut Microbes. 2016;7:246–261. doi: 10.1080/19490976.2016.1156827. - DOI - PMC - PubMed
    1. Grattan B.J., Jr., Bennett T., Starks M.R. Diaphragm disease: NSAID-induced small bowel stricture. Case Rep. Gastroenterol. 2018;12:327–330. doi: 10.1159/000489301. - DOI - PMC - PubMed
    1. Caron M.M.J., Emans P.J., Sanen K., Surtel D.A.M., Cremers A., Ophelders D., van Rhijn L.W., Welting T.J.M. The role of prostaglandins and COX-enzymes in chondrogenic differentiation of ATDC5 progenitor cells. PLoS ONE. 2016;11:e0153162. doi: 10.1371/journal.pone.0153162. - DOI - PMC - PubMed
    1. Rangarajan S., Rezonzew G., Chumley P., Fatima H., Golovko M.Y., Feng W., Hua P., Jaimes E.A. COX-2-derived prostaglandins as mediators of the deleterious effects of nicotine in chronic kidney disease. Am. J. Physiol. Renal Physiol. 2020;318:F475–F485. doi: 10.1152/ajprenal.00407.2019. - DOI - PMC - PubMed

LinkOut - more resources